The short version
- Women with autoimmune conditions are up to 74% more likely to receive psychosomatic misdiagnoses compared to men.
- Female patients reported waiting one to two years for a diagnosis, whereas most men received answers within three months.
- Researchers attribute these disparities to historical medical biases that may undermine the credibility of female symptom reports.
A new study led by researchers at the University of Cambridge and the University of East Anglia highlights a significant gender disparity in how autoimmune conditions are diagnosed and treated. The research, published in the journal eClinicalMedicine, suggests that women are substantially more likely than men to have their physical symptoms attributed to psychological or psychosomatic causes. This misattribution often results in delayed treatment and prolonged periods of uncertainty for female patients.
Autoimmune diseases, which occur when the immune system mistakenly attacks healthy tissue, affect approximately one in ten people globally. These conditions can manifest through a wide variety of symptoms, including fatigue, muscle pain, rashes, and weight changes. Because these signs are common across many different health issues, diagnosing autoimmune disorders is inherently complex for both men and women. However, the study indicates that this diagnostic difficulty disproportionately impacts women.
The analysis included data from more than 6,600 individuals with autoimmune conditions, the majority of whom were female and located in the United Kingdom. Among the participants, nearly a quarter of the women suffered from autoimmune thyroid diseases, such as Hashimoto’s or Graves’ disease. One in seven women reported having systemic lupus. In contrast, male patients most frequently presented with rheumatoid arthritis, vasculitis, or antiphospholipid syndrome.
The findings reveal a stark difference in how doctors interpret symptoms based on gender. Forty-three percent of women reported being told their condition was psychiatric in nature, compared to 33% of men. Furthermore, 34% of women said their symptoms were misdiagnosed as psychosomatic, meaning they were believed to be triggered or worsened by stress or anxiety. Only 22% of men received this type of explanation for their physical ailments.
After adjusting for variables such as age, specific disease group, geographic location, and household income, the disparity remained significant. Women were found to be 46% more likely than men to report receiving a psychiatric misdiagnosis. The gap widened further regarding psychosomatic explanations, with women being 74% more likely to receive this assessment. These statistics suggest that gender plays a critical role in how medical professionals evaluate and respond to patient complaints.
The consequences of these misdiagnoses extend beyond incorrect labels; they directly impact the timeline for receiving appropriate care. The study found that women experienced much longer intervals between the onset of symptoms and a confirmed diagnosis. While the most frequently reported time to diagnosis for men was less than three months, women typically waited one to two years. During this period, female patients also reported undergoing more healthcare consultations without resolution.
Melanie Sloan, the lead author of the study, emphasized that the damage caused by these errors can be long-lasting. She noted that such experiences erode trust in medical professionals and negatively affect patients’ self-esteem. Sloan argued that psychological explanations are often offered too quickly, particularly for women, whose symptoms may be viewed with less credibility due to historical biases in medicine.
Shaista Tayabali, a patient advocate and co-author of the research, pointed out that while outdated terms like hysteria are rarely used today, the underlying skepticism toward female patients persists. The study suggests that these historical gender biases remain a challenging aspect of the diagnostic journey. Researchers concluded that it is vital for doctors to believe patients with invisible symptoms rather than automatically assuming a mental health origin.
The authors acknowledge that broader diagnostic challenges affect all sexes, given the complex nature of autoimmune diseases. However, they stress that females face additional disadvantages in the healthcare system. The findings call for a reevaluation of how symptoms are assessed to ensure that gender does not influence the accuracy or speed of medical diagnoses.
As the medical community grapples with these findings, the study serves as a reminder of the need for equitable care. Ensuring that all patients, regardless of gender, receive timely and accurate diagnoses requires addressing deep-seated biases in clinical practice. Future research may focus on developing better diagnostic tools and training programs to mitigate these disparities.
Sources behind this briefing
Go to the original reporting
- The Guardian World↗Women ‘more likely to be told autoimmune conditions are psychological’
